Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
The Journal of Clinical Endocrinology and Metabolism|December 15, 2025
Approach to the Patient with Cushing's Syndrome: Use of Anticoagulation TherapyKristina Isand, John Wass, Niki Karavitaki, et al.
Clinical Endocrinology|April 23, 2024
Increased mortality in acromegaly is due to vascular and respiratory disease and is normalised by control of GH levels-A retrospective analysis from the UK Acromegaly Register 1970-2016Steve Orme, Richard McNally, Peter W James, et al.
Clinical Endocrinology|February 4, 2025
The Cost of Adrenal Insufficiency in England-Analysis of NHS HES DataRobert D Murray, Leonardo Ruiz-Casas, Matthew Beckett, et al.
European Journal of Endocrinology|March 29, 2007
Effects of GH on cognitive function in elderly patients with adult-onset GH deficiency: a placebo-controlled 12-month studyMahesh Sathiavageeswaran, Pia Burman, David Lawrence, et al.
Clinical Obesity|August 14, 2025
Commissioning of Tier 3 Obesity Services by Integrated Care Boards in England: An Analysis of Responses to Freedom of Information RequestsNicholas Finer, Nikolaos Fragkas, Alexander Dimitri Miras, et al.
Drug Discovery Today|August 24, 2010
Ligand efficiency indices for an effective mapping of chemico-biological space: the concept of an atlas-like representationCele Abad-Zapatero, Ognjen Perišić, John Wass, et al.
Obesity Surgery|January 8, 2016
NICE-Accredited Commissioning Guidance for Weight Assessment and Management Clinics: a Model for a Specialist Multidisciplinary Team Approach for People with Severe ObesityRichard Welbourn, John Dixon, Julian H Barth, et al.
BMC Cancer|August 31, 2010
Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of BoneMaurice Balke, Laura Campanacci, Carsten Gebert, et al.
Hormones (Athens, Greece)|February 21, 2013
Diagnostic and therapeutic review of cystic parathyroid lesionsNikolaos Pontikides, Spyros Karras, Athina Kaprara, et al.
Clinical Endocrinology|October 19, 2017
Males with prolactinoma are at increased risk of incident cardiovascular diseaseKonstantinos A Toulis, Tim Robbins, Narendra Reddy, et al.
Pageof 5